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Abstract
The Synaptic Vesicle Protein 2 (SV2) family of transporter-like proteins is expressed exclusively in vesicles that undergo
calcium-regulated exocytosis. Of the three isoforms expressed in mammals, SV2B is the most divergent. Here we report
studies of SV2B location and function in the retina. Immunolabeling studies revealed that SV2B is detected in rod
photoreceptor synaptic terminals where it is the primary isoform. In mice lacking SV2B, synaptic transmission at the synapse
between photoreceptors and bipolar neurons was decreased, as evidenced by a significant reduction in the amplitude of
the b-wave in electroretinogram recordings. Quantitative immunoblot analyses of whole eyes revealed that loss of SV2B was
associated with reduced levels of synaptic vesicle proteins including synaptotagmin, VAMP, synaptophysin and the vesicular
glutamate transporter V-GLUT1. Immunolabeling studies revealed that SV2B is detected in rod photoreceptor synaptic
terminals where it is the primary isoform. Thus, SV2B contributes to the modulation of synaptic vesicle exocytosis and plays
a significant role in regulating synaptic protein content.
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Introduction
The secretion of neurotransmitter can be distinguished from
other forms of exocytosis by its strict dependence on calcium,
speed, and plasticity. These specialized features are conferred by
proteins unique to regulated secretion, including some isoforms of
synaptotagmin, complexin, cytomatrix proteins (reviewed in [1,2]),
and Synaptic Vesicle Protein 2 (SV2). All of these proteins are
members of multi-gene families with isoforms that are co-
expressed to varying degrees in different neuronal cells. Differ-
ences in isoform action, expression, and localization are
hypothesized to contribute to differences in neuronal and
endocrine cell functioning.
SV2 is a gene family that consists of three highly related
membrane glycoproteins in mammals (SV2A, SV2B, SV2C)
[3,4,5,6]. Of the three isoforms, SV2B is the most divergent. In
contrast to SV2A and SV2C, SV2B lacks significant portions of
the cytoplasmic amino terminus, which mediates protein interac-
tions in SV2A and SV2C [7]. SV2B also lacks regions of the large
lumenal domain between transmembrane domains 7 and 8 that
are present in SV2A and SV2C [5]. SV2B mRNA expression
shows developmental variation, being more broadly expressed in
neonatal brain than adult brain consistent with it playing a role in
synapse development [8]. Finally, SV2B has been reported to be
the exclusive SV2 isoform in ribbon synapses in retina and the
pineal gland [9,10]. Together these observations support the idea
that SV2B may function differently in the synapse than other SV2
isoforms. On the other hand, loss of SV2B does not appear to
affect neurotransmission in neurons that also express SV2A, which
is consistent with the two isoforms performing an identical
function, or SV2B performing only a subset of functions
performed by SV2A [11,12].
To identify the role of SV2B at the synapse, we examined the
effects of SV2B gene disruption on neurotransmission in retina,
thereby taking advantage of the reported absence of SV2A in
ribbon synapses.
Methods
Antibodies
Anti-Glyceraldehyde-3-phosphate dehydrogenase, (GAPDH)
mAb was from CalbioChem. Anti- Synaptophysin, p38 mAb
and anti-Vesicular glutamate transporter 1, Vglut1 mAb were
from Millipore. The anti-synaptophysin antibody produces no
labeling in tissue from synaptophysin knockout mice [13]. The
anti-vglu1 antibody antibody produces no labeling of samples from
Vglut1 knockout mice [14]. Anti-Vesicle associated membrane
protein 2, Vamp2 mAb and the anti-SV2B used for immunolabel-
ing were from Synaptic Systems. The antibody against VAMP2
does not label tissue from VAMP-2 knockout mice [15]. Anti-
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SV2 B (here and [8]). Anti-SV2 mAb [16] and anti-synaptotagmin
mAb M48 [17] were generated from cells provided by Dr. R.
Kelly. Anti-SV2A pAb was generated against the first 20 residues
of rat SV2A . This antibody does not label cells that do not express
SV2A [8] and produces no labeling of brain homogenates from
SV2A knockout mice [18]. Anti-synaptotagmin pAb was gener-
ated against the cytoplasmic domain of rat synaptotagmin 1 [19].
Generation of SV2B minus mice
A portion of the SV2B gene was isolated from a mouse 129SV
genomic library (Stratagene) by screening with a PCR-generated
probe encoding bases 60–245 of the rat SV2B cDNA. A fragment
of approximately 7.5 kb was subcloned from the genomic library.
This fragment contained the exon encoding the translation start
site through most of the first transmembrane domain of the SV2A
cDNA. A targeting construct was generated in which this exon and
surrounding DNA were replaced with a gene encoding neomycin
phosphotransferase as illustrated in Figure 1. DNA encoding
thymidine kinase was placed at the end of the short arm of the
targeting construct to allow for negative selection against non-
homologous recombination using the antiviral agent gancyclovir.
Embryonic stem cells were grown on feeder layers of mouse
embryonic fibroblasts, generated from mice transgenic for the
neomycin resistance gene that had been pre-treated with
mitomycin C to prevent proliferation. Cells were grown in
DMEM with 15% fetal calf serum, penicillin/streptomycin, non-
essential amino acids, and leukemia inhibitory factor. ES cells were
transfected at a density of 1.2610
7 cells/ml with 25 ug/ml
linearized targeting construct by electroporation. Cells were
placed under selection in G418 (Gibco/BRL) and Gancyclovir
(a gift from Syntex Corporation). Resistant colonies were screened
for homologous recombination by Southern analysis of HindIII
digested genomic DNA using the probe depicted in Figure 1.
Three cell lines carrying the SV2B disruption were injected into
C57BL/6 blastocysts and implanted into pseudopregnant females.
Pups were evaluated for ES cell incorporation by coat color. One of
five chimeric males produced offspring heterozygous for the SV2B
gene disruption. These offspring were bred with each other to
produce animals homozygous for the mutation. A line of genetically
matched wild-type mice was generated from the wild-type offspring
of heterozygote (SV2B+/2) crosses and used as control animals.
Unless indicated, studies were conducted with animals that were, on
average 50% 129/SVJ and 50% C57BL/6. All animals used in
these studies were genotyped by Southern analysis of DNA isolated
from tail clippings as indicated in Figure 1.
Immunohistochemistry
Immunolabeling of retina sections was performed as described
previously [20,21]. Briefly, mouse eyecups were prepared from
freshly dissected eyes. Eyecups were fixed by immersion in freshly
prepared, ice cold 4% (w/v) paraformaldehyde in phosphate
buffer (0.1 M, pH 7.4) for 20 minutes, washed in phosphate buffer
(0.01 M, Ph 7.4) and then cryoprotected by consecutive immersion
in cold 10% and 20% sucrose in phosphate buffered saline (PBS)
for 1–2 hrs each, then transferred to vials of 30% sucrose and left
overnight at 4uC. The tissue was embedded in OCT (Sakura
Finetek, Torrence, CA), frozen, and cut at 15 mm thickness on a
cryostat. Sections were mounted onto Super-Frost glass slides, air-
dried and stored at 280uC until used for staining. After thawing to
room temperature (RT), eyecup sections were blocked by
incubation at RT for 30–60 min in antibody incubation solution
[AIS: 3% (v/v) normal horse serum, 60.5% (v/v) Triton X-100,
0.025% (w/v) NaN3 in PBS]. The sections were then incubated
Figure 1. Generation of SV2B knockouts. A) Targeting construct. A
region of the SV2B gene containing the first exon (depicted as a black
box) was cloned from a mouse 129/SVJ genomic library. The genomic
fragment was used to generate the indicated targeting vector in which
exon 1 was replaced with a gene encoding neomycin resistance. A
thymidine kinase gene, which makes cells sensitive to gancyclovir was
placed at the end of the targeting construct to allow for negative
selection of non-homologous recombination events. The mutant gene
produces a smaller HindIII (H3) restriction fragment as detected in
Southern analyses with a probe indicated by the band above the
disrupted gene. Notation key: H2=HindII restriction site, H3=HindIII
restriction site, RV=EcoRV restriction site, neo=DNA encoding
neomycin resistance, TK=DNA encoding thymidine kinase. B) Southern
blot of Hind III-digested genomic DNA from littermates resulting from
the crossing of heterozygous breeders demonstrating the production of
mice homozygous for the SV2B gene disruption. C) SV2 expression in
brain of SV2B mutants. 25 ug of a Triton X-100 extract of whole brain
was probed with antibodies to the indicated protein. Antibody binding
was visualized with HRP-conjugated secondary antibody reacted with
enhanced chemiluminescence (ECL) reagent and exposed to film.
Disruption of the SV2B gene results in loss of full length SV2B and a
decrease in total SV2. Data are representative of experiments from two
series of mice.
doi:10.1371/journal.pone.0005230.g001
SV2B Knockout
PLoS ONE | www.plosone.org 2 April 2009 | Volume 4 | Issue 4 | e5230with primary antibody diluted in AIS for either 1–2 h at RT or at
4uC overnight. Mouse retina sections from SV2B knockout and
wild-type littermates were labeled with primary antibodies against
SV2 (1:200), SV2A (1:1000), SV2B (1:100), vGlut1 (1:1000),
synaptophysin (1:500), ribeye (ctbp2; 1:5000; BD Transduction
Laboratories), beta-2 calcium channel subunit (1:100; Chemicon
International), Cav1.4 (1:20; Morgans et al., 2005), and synapto-
tagmin (1:1000). Secondary antibodies coupled to either CY3
(Jackson ImmunoResearch Laboratories, West Grove, PA),
Alexa488, or Alexa594 (Invitrogen) were used at dilutions of
1:500 to 1:2000. For some antigens (synaptotagmin, SV2A and
SV2B), peanut agglutinin-Alexa488 was added to Alexa594-
coupled secondary antibody solutions at a 1:1000 dilution in
order to visualize cone terminals. Images were acquired at a
resolution of 102461024 on an Olympus Fluoview1000 confocal
imaging system with a 606/1.42 oil immersion objective. All
confocal figures show single optical sections of ,1 mm thickness.
For figures, Adobe Photoshop 7.0 was used to adjust brightness
and contrast uniformly across the image with identical adjustments
made to pairs of knockout and wild-type images.
Analyses of protein expression
Protein expression was determined by immunoblot analysis of
Triton X-100 extracts or post-nuclear supernatants of whole brain
obtained from littermate pups of heterozygote crosses. To assess
expression in eyes, eyes were pooled and homogenized in
phosphate buffered saline after which Triton X-100 was added
to a final concentration of 1%. The mixture was extracted 1–
2 hours with gentle agitation after which insoluble material was
removed by centrifugation at 19,0006 g for 30 min. To assess
expression in brain, post-nuclear supernatants of brain were made
by homogenizing brains in 20 mM Hepes pH 7.5, 250 mM
sucrose, 2 mM MgCl2 and centrifuging at 13006g for 5 minutes.
Protein concentration was assayed using the Biorad Coomasie-
based protein assay with bovine serum albumin as a standard.
Equal amounts of protein from wild-type, heterozygous and
homozygous littermates were separated on 12.5% SDS-PAGE gels
and transferred to PVDF (0.45um, Millipore) in 20% MeOH,
25mM Tris, 192 mM Glycine. Transfer was done at 100 volts for
1h ra t4 uC. Blots were stained with Ponceau Red to verify
equivalent loading across lanes. Blots were blocked 5% milk in
phosphate buffered saline with 0.025% Tween 20. Incubations
with the primary antibody were done inblocking buffer, either for
1 hour at RT or O/N at 4uC with agitation. Blots were washed a
minimum of 3615 min in phosphate buffered saline with 0.025%
Tween 20 and then incubated for 1–2 hr at rt in HRP-conjugated
secondary antibodies diluted in the blocking buffer. Binding of the
HRP-conjugated secondary antibody was detected with Super-
Signal West Dura reagent (Pierce/Thermo), and the images were
acquired and analyzed using a Kodak Image Station 440 and
analyzed with Kodak software.
ERG analyses were performed as previously described [22].
Briefly, 5–6 week old mice were dark-adapted overnight and
anaesthetized with intraperitoneal injection of Ketamine and
Xylazine (140 mg/kg and 0.5 mg/kg body weight respectively).
Pupils were dilated by topical application of tropicamide and
phenylephrine 15–20 minutes before any ERGs were recorded.
Mice were maintained at 37uC throughout the recording sessions.
All manipulations were done under infrared illumination. Flashes
were delivered from a photographic flash unit focused on the eye
through a fiber optic cable and lens. A gold ring electrode
embedded in a contact lens (Bayer, 2000) was placed on a drop of
2–3% methylcellulose on the cornea and a copper reference
electrode was placed in the mouth. ERG signals were amplified
10,0006, filtered between 1 Hz to 3 kHz and sampled at 5 kHz.
Responses to test flashes from dim to moderate intensity caused 9,
90, 900, 9000, and 90,000 photoisomerisations per rod in dark
adapted wild-type mice. Littermate pairs resulting from SV2B +/
2 crosses were used at a minimum of 4 weeks of age. Both 50%
129/SVJ and 50%, C57BL/6 and 99.9% C57BL/6 (F12) genetic
backgrounds were used.
Results
Targeted disruption of the SV2B gene
A portion of the SV2B gene containing a single exon encoding
the translation start site through the beginning of transmembrane
domain 2 was isolated from a mouse 129/SVJ genomic library as
described under Experimental Procedures. This genomic fragment was
incorporated into the targeting construct depicted in Figure 1A
and was used to generate mice homozygous for the SV2B gene
disruption (Figure 1B). Animals homozygous for the SV2B gene
disruption constitute approximately one quarter of live births
resulting from the mating of heterozygous mutants and are viable
and fertile. This indicates that SV2B is not essential for survival
and contrasts with loss of SV2A, which generally results in death
within 21 days of birth [12,18].
Brain homogenates from SV2B 2/2 mice lacked detectable
SV2B protein as detected by immunoblot (western) analysis
(Figure 1C), indicating that full-length SV2B protein is absent
and thus confirming disruption of expression. Total SV2, detected
with a monoclonal antibody that recognizes all known isoforms
[16], was also reduced in the brain of SV2B knockouts as expected.
However, this reduction was less than observed in SV2A knockouts
[18], indicating that SV2B is not the primary SV2 isoform in brain
(Figure 1C). Northern analysis of RNA isolated from the brains of
SV2B knockout homozygotes revealed the absence of full-length
SV2B mRNA, though a smaller RNA hybridized to SV2B cDNA
probes (data not shown). Because all available anti-SV2B antibodies
are directed against the amino terminus of SV2B, we cannot rule
out the possibility that a truncated SV2B protein is expressed. We
note, however, that the next possible codon for methionine that
would produce an in-frame message is in the region encoding the
cytoplasmic domain preceding transmembrane domain 6. Given
that many point mutations in SV2 lead to improper protein
trafficking ([23] and our unpublished observations), it is highly
unlikely that a truncated SV2B is expressed in synapses. We cannot
entirely rule out the possibility, however, that a truncated protein is
contributing to the effects we observe.
SV2B is the primary but not exclusive SV2 isoform in rod
photoreceptor synapses
We examined SV2A, SV2B and total SV2 in retina from wild-
type and SV2B knockout mice using isoform-specific antibodies
and an antibody that recognizes all three isoforms. SV2B was
previously reported to be the sole SV2 isoform in rod
photoreceptor synapses [9] and we therefore anticipated that
these synapses would lack all SV2 in SV2B knockouts. We
compared the presence of SV2A and SV2B to the cone marker
peanut agglutinin (PNA) in retina from wild-type and SV2B
knockout mice. As previously reported, we observed strong SV2A
immunoreactivity in PNA-positive cone terminals, and SV2B
immunoreactivity primarily in rod (PNA-negative) terminals in the
outer plexiform synaptic layer (OPL) of wild-type mice, (Figure 2).
In contrast to the findings of Wang et al. (2003), however, we
observed faint labeling of PNA-negative synapses with anti-SV2A,
indicating that SV2A is expressed in rod synapses. This labeling of
rod terminals is unlikely to be a fixation artifact, since the sections
SV2B Knockout
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Also in contrast to the findings of Wang et al. (2003), we saw little
SV2B labeling in the inner plexiform layer, consistent with SV2B
being expressed primarily in rod photoreceptor terminals.
Total SV2 was significantly reduced in the OPL of retina from
SV2B knockout mice, where the labeling pattern was indistin-
guishable from anti-SV2A labeling (Figure 2). These results
support the conclusion that SV2B is the primary, though not
exclusive, SV2 isoform in rod photoreceptor synapses. Thus both
our results and those of Wang et al. support the conclusion that
SV2B is the primary SV2 isoform found at rod synapses.
Loss of SV2B leads to reduced neurotransmission in the
ribbon synapses between photoreceptors and bipolar
neurons of the retina
To explore the function of SV2B, we compared neurotrans-
mission in the retinas of wild-type and SV2B knockout mice by
measuring the electroretinographic response to light flashes of
varying intensity [22]. This procedure measures electric potential
flux in the retina. The amplitudes of the a-wave component of the
measure, which reflects closure of cGMP-gated ion channels in the
outer segment membrane, were not significantly different in
SV2B2/2 retinas (Figure 3C), indicating that the channels
regulating membrane conductance in photoreceptors function
normally in the absence of SV2B. In contrast, b-wave amplitudes,
which reflect synaptic transmission between photoreceptors and
bipolar neurons, were reduced ,30% in retinas of SV2B2/2
mice compared to SV2B+/+ mice (Figure 3A–B). Decreased b-
wave amplitudes were observed at stimulus intensities in which
only rod photoreceptors were activated (9 and 900 photoisomer-
isations/sec) and those in which both rods and cones were
activated (9000 and 90,000 photoisomerisations/sec) (Table 1).
When b-wave amplitudes were normalized by calculating the b/a
wave ratio, we observed that values from SV2B knockouts were
,50% lower at the two highest stimulus intensities (Figure 3D).
Figure 2. SV2A and SV2B are differentially distributed in photoreceptor terminals. A) SV2A is expressed in both inner and outer plexiform
layers whereas SV2B is expressed primarily in the outer plexiform layer. Retina sections from SV2B knockout (2/2) and wild-type (+/+) mice were
labeled by fluorescence with antibodies recognizing all SV2 subtypes (total SV2), or antibodies specific for either SV2A or SV2B. B) SV2A is the
predominant SV2 isoform in cone terminals and SV2B predominates in rod terminals. The outer plexiform layer is shown for wild-type retina sections
double labeled for peanut agglutinin (PNA) conjugated to Alexa-488 (green) and either SV2A or SV2B (red). Areas of overlap between the two
fluorophores appear yellow. Both anti-SV2A and anti-SV2B labeled PNA-negative synapses, consistent with both isoforms being present in rod
photoreceptor terminals. Abbreviations: opl, outer plexiform layer; ipl, inner plexiform layer. The scale bars represent 30 mm.
doi:10.1371/journal.pone.0005230.g002
SV2B Knockout
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SV2B 2/2 mice did not reveal obvious differences in photore-
ceptor synapse ultrastructure (Supplemental Figure S1). This
contrasts with the striking change in ribbon morphology observed
in Bassoon knockout mice, which demonstrate a similar neuro-
transmission phenotype [24]. Thus diminished transmission
between photoreceptors and bipolar neurons does not appear to
be due to gross changes in ribbon synapse development. Taken
together, these observations indicate that SV2B, like SV2A
[18,25], is a positive modulator of synaptic transmission.
Levels of several synaptic vesicle proteins are reduced in
eyes of SV2B knockouts
All SV2 isoforms bind to the synaptic vesicle protein
synaptotagmin [7,19,26], and loss of SV2B has been reported to
produce a selective loss of synaptotagmin 1 in the outer plexiform
synaptic layer of the retina [26]. To quantify changes in synaptic
vesicle protein expression, we compared the levels of synaptotag-
min and other synaptic vesicle proteins in eyes of SV2B wild-type
and knockout mice by quantitative Western analysis. Eyes from
multiple mice of each genotype were pooled and homogenates
probed with antibodies directed against the synaptic vesicle
proteins SV2 (total), SV2A, SV2B, synaptotagmin, synaptophysin,
the vesicular glutamate transporter V-glut1, and VAMP. The
amount of protein loaded was adjusted for each antibody so that
signal intensity fell within the linear range of the assay
(Supplemental Figure S2). Samples from each genotype were
run multiple times in each blot to control for variability. The
average value for SV2B2/2 eyes was expressed as the percent of
the average value for SV2B+/+ eyes from the same blot. These
analyses revealed decreased levels of synaptotagmin, synaptophy-
sin, V-Glut-1, and VAMP in eyes from SV2B2/2 mice
(Table 2). Levels of SV2A and GAPDH (which is found on
synaptic vesicles but is also present in all cells of the eye) did not
change with the loss of SV2B. Since the retina is the major site of
synapses in the eye, these data indicate that multiple synaptic
vesicle proteins are reduced in retinal synapses in the absence of
SV2B. While the reduction in protein expression we observed may
seem large given the localized expression of SV2B in the retina, we
note that photoreceptor synaptic terminals contain hundreds of
thousands of synaptic vesicles per synapse. This contrasts with the
tens to hundreds of vesicles in the synapses of the inner retina. It is
therefore likely that, although there are many more synapses in the
inner retina, the pool of photoreceptor synaptic vesicles represents
the majority of retinal synaptic vesicles.
While the quantitative western blotting data point to a general
decrease in synaptic vesicle proteins in the eye they do not indicate
whether different types of synapses are differentially affected. To
assess the location of the changes in protein expression, we probed
retina sections with antibodies to multiple synaptic proteins.
Immunolabeling with antibodies that recognize synaptotagmin 1
and 2 revealed a reduction, though not a complete absence, of
synaptotagmin labeling in the outer plexiform layer of SV2B2/2
mice, particularly in rod terminals (Figure 4). This is in
Figure 3. Loss of SV2B results in reduced neurotransmission
between photoreceptors and bipolar neurons of the retina. A)
Average ERG traces from wild-type and SV2B2/2 retina in response to
stimuli of (top to bottom) 90,000, 9,000, 900, 90 and 9 photo-
isomerizations per rod per flash. (n=5 wt, 8 SV2B2/2 mice). B) Average
b-wave amplitudes at different light intensities showing average
intensity decrease in mice from SV2B knockouts (n=5 wt, 8 SV2B2/2
mice). Error bars represent S.E.M. C) Average a-wave amplitudes
showing no difference in amplitude in wt and SV2B knockouts. D)
The ratio of b- to a-wave amplitude at the two strongest stimulus
intensities was ,50% lower in SV2B2/2 mice (p=0.015 for 90,000,
p=0.026 for 9000, students t-test).
doi:10.1371/journal.pone.0005230.g003
SV2B Knockout
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2004) and is consistent with the interpretation that SV2B plays a
crucial role in synaptotagmin trafficking or stability in rod
photoreceptor synapses. We also saw a slight reduction in
VGLUT1 labeling of putative rod bipolar cell terminals in the
inner IPL (Fig. 4A), whereas there was no apparent decrease in
other synaptic proteins including synaptophysin, synaptic ribbons
(ribeye) and the presynaptic calcium channel proteins, Cav1.4 and
b2 subunits (data not shown). This may be due to the non-
quantitative nature of the immunolabeling approach, or to a
generalized reduction of other synaptic proteins in the absence of
SV2B. What our immunolabeling studies do show is that the
decrease of synaptotagmin expression in the retina of mice lacking
SV2B is limited to rod photoreceptor terminals in the OPL.
Discussion
The findings presented here indicate that loss of SV2B reduces
neurotransmission at rod photoreceptor synapses. This is the only
physiological phenotype identified to date in SV2B knockout mice
and contrasts with the normal neurotransmission observed in CNS
synapses of these mice [11,12]. The decrease is unlikely to be due
to effects on synapse formation, as the gross morphology of
synapses was normal. This contrasts to the ‘‘floating ribbon’’
phenotype seen in Bassoon knockouts [24], or the structural
abnormalities obvious in electron micrographs of Gbeta5
knockouts [27], both of which produce similar effects on the
ERG. Our results demonstrate that, like SV2A, SV2B acts as a
positive modulator of neurotransmission, consistent with the
conclusion that all SV2 proteins perform a similar function in
regulating presynaptic exocytosis. Thus SV2B is likely to represent
a target for therapeutic intervention analogous to SV2A, which is
the target of the anti-epileptic drug levetiracetam [28].
We also found that loss of SV2B alters synaptic protein
expression in the eye. Previous studies of retinal protein expression
in SV2B knockouts revealed a selective loss of synaptotagmin 1 in
the outer plexiform layer (OPL) of the retina [26], which the
authors attributed to a selective interaction between SV2B and
synaptotagmin. While we confirmed the effect on synaptotagmin,
quantitative Western analyses to revealed that loss of SV2B also
affects the levels of synaptophysin, VAMP and V-GLUT1. Thus
SV2B has a broader effect on the levels of synaptic vesicle protein
expression than was previously demonstrated. In a series of (non-
quantative) anti-synaptophysin immunoblots we observed that
samples from SV2B2/2 mice showed a reduction in bands that
migrated at the molecular weight of VAMP-synaptophysin
complexes [29,30] (data not shown). This suggests that loss of
SV2 may affect the ability of VAMP to form protein complexes,
an interpretation consistent with the finding that loss of the SV2A
gene results in a reduction in assembled (SDS-resistant) SNARE
complexes [25].
The presence of SV2A in rod photoreceptor presynaptic
terminals, coupled with the observation that the decrease in
synaptotagmin labeling in the OPL of SV2B2/2 mice correlates
well with the decrease in total SV2 immunolabeling suggests that
the remaining synaptotagmin is being stabilized by SV2A. Thus it
is likely that all SV2 isoforms contribute to synaptic vesicle protein
composition. Our finding, that loss of SV2B affects the levels of
multiple synaptic proteins, is consistent with a role for SV2 in
endocytosis. SV2s contain one or more tyrosine-based endocytosis
motifs that can affect the ability of the clathrin adaptor protein
AP2 to bind to synaptic membranes, in part by affecting AP2
binding to synaptotagmin [31]. Thus, SV2 could influence the
trafficking of proteins to synaptic vesicles by regulating clathrin-
mediated endocytosis of vesicle proteins. Alternatively, SV2 might
regulate the trafficking of vesicle membrane proteins from the ER/
Golgi. We note with interest that the transporter-like protein,
unc93b, is essential for proper trafficking of a subset of Toll
receptors, which are type 1 membrane proteins like several
synaptic vesicle proteins [32,33]. In this regard, SV2 might affect
the conformation and stability of vesicle membrane proteins by
directly interacting with them and affecting their trafficking or
folding.
If SV2 plays a major role in vesicle assembly, the neurotrans-
mission deficit we observed could result entirely from altered
Table 1. ERG b-wave amplitudes are decreased in the retina of mice lacking SV2B.
R* per rod per flash SV2B+/+ SV2B2/2 KO/wt ratio p (t-test)
90,000 181 +/2 11 (n=4) 113 +/2 22 (n=8) 0.62 0.065
9,000 172 +/2 33 (n=5) 124 +/2 22 (n=8) 0.72 0.114
900 209 +/2 35 (n=5) 137 +/2 20 (n=8) 0.65 0.038
90 229 +/2 32 (n=5) 166 +/2 23 (n=8) 0.72 0.065
91 8 7 +/2 25 (n=5) 166 +/2 19 (n=8) 0.89 0.258
Mean hyperpolarization amplitudes +/2 S.E.M. in response to light flashes of the indicated intensity.
doi:10.1371/journal.pone.0005230.t001
Table 2. Loss of SV2B decreases the expression of several
synaptic vesicle proteins.
Protein % wild-type
SV2B 0.3 +/20
SV2A 98 +/2 5
SV2 (total) 57 +/2 13
Synaptotagmin (mAb) 61 +/2 4
Synaptotagmin (pAb) 44 +/2 8
Synaptophysin 55 +/2 5
VAMP2 71 +/2 5
V-glut1 66 +/2 4
GAPDH 102 +/27
Eyes from two SV2B+/+ and two age-matched SV2B2/2 mice were pooled and
extracted after which equal amounts of protein processed for quantitative
Western analysis as described under Methods. Each sample was run six times on
a minimum of three blots. The ratio of average values (KO/wt) was calculated
for each blot and the ratios averaged across blots. All proteins except SV2A and
GAPDH were reduced compared to wild-type levels. Results are representative
of another study done with eyes pooled from 4 mice of each genotype.
doi:10.1371/journal.pone.0005230.t002
SV2B Knockout
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we did not observe a gross decrease in the number of vesicles in
photoreceptor synapses - or in central synapses in SV2A knockouts
[18] - SV2 does not appear to contribute to vesicle formation per se.
Future work on the roles of SV2 in vesicle priming and protein
trafficking will address whether it plays multiple roles at the
synapse. What the findings presented here make clear is that SV2B
influences the composition of synaptic vesicles. Thus, SV2 proteins
may play a structural role in vesicle biogenesis, a process essential
to normal neurotransmission.
Supporting Information
Figure S1 Representative electron microscopic images of retina
from two SV2B wild-type and two SV2B knockout (2/2) mice.
Arrows point to ribbon synapses. Electron Microscopic Analyses:
Retinas were dissected from eyes of two wild-type and two SV2B
knockout mice and fixed in 2% paraformaldehyde, 2.5%
glutaraldehyde, 0.1M Cacodylate pH 7.3, 0.1% CaCl2 overnight
at 4uC. Tissue was washed 36 over 30’ with 0.1M Cacodylate,
pH 7.3, 0.1% CaCl2, post fixed in 1% OsO4, 1% Potassium
Ferrocyanide, 0.1M Na Cacodylate pH 7.3, 1 hr on ice, and
washed in double distilled water (ddH2O) 36and stored overnight
at 4uC. Tissue was stained with 2% aqueous Uranyl Acetate (1 hr,
rt), washed in ddH2O and dehydrated in a graded series of ethanol
washes. Dehydrated blocks were incubated in Propylene Oxide,
26 10 min and infiltrated with Spurrs’s Low Viscosity Epoxy.
Thin sections of embedded tissue (90–100 nm) were stained with
7% UA and Reynolds Lead Citrate. Images were collected at
60,0006and 75,0006magnification by a specialist blind to mouse
genotype. Electron microscopy was performed at the University of
Washington Department of Pathology EM Facility
Found at: doi:10.1371/journal.pone.0005230.s001 (247.34 MB
PPT)
Figure S2 Calibration blots and Western data. Shown are blots
andgraphsof the s ignal intensityobtained from increasing amounts
of postnuclear supernatant from wild-type eye probed with the
indicated antibody. Also shown are representative quantitative blots
showing wild-type and SV2B KO sample replicates.
Found at: doi:10.1371/journal.pone.0005230.s002 (0.37 MB
PDF)
Figure 4. Distribution of synaptic vesicle proteins in SV2B knockout (2/2) and wild-type (+/+) retina. A) Synaptotagmin labeling is
markedly reduced in the OPL of the 2/2 retina. Retina sections from SV2B 2/2 and +/+ mice were labeled by immunofluorescence with antibodies
against synaptotagmin or vGluT1. Negligible differences were observed for vGluT1 in the OPL between the 2/2 and +/+ retina sections, whereas
synaptotagmin labeling was visibly reduced in the OPL. B) Synaptotagmin in OPL synapses of SV2B 2/2 retina is primarily associated with cone
terminals. The OPL of SV2B 2/2 and +/+ mice was double labeled for synaptotagmin (red) and the cone marker, PNA-Alexa 488 (green). A small
amount of synaptotagmin labeling remains in PNA-negative synapses in the SV2B 2/2 OPL; however, the majority of the remaining labeling is
associated with cone terminals, suggesting that synaptotagmin levels are significantly reduced in rod terminals. Abbreviations: opl, outer plexiform
layer; ipl, inner plexiform layer. The scale bars represent 30 mm.
doi:10.1371/journal.pone.0005230.g004
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